scoliosis
发表于 2025-3-23 11:09:29
http://reply.papertrans.cn/63/6226/622576/622576_11.png
Muffle
发表于 2025-3-23 15:20:51
Imaging and Clinical Staging for Penile Cancer,asound. FNA cytology confirms metastasis; .F-FDG PET/CT is indicated to detect pelvic or distant metastasis and to specify the number of inguinal lymph node metastases. In patients at high risk of metastasis but without palpable lymph nodes and when ultrasound-guided fine-needle aspiration cytology
存心
发表于 2025-3-23 22:02:20
Surgical Management of the Clinically Negative and Locally Advanced Inguinal Region in Patients witectomy vs. careful observation, (2) the types of procedures to correctly stage the inguinal region with low morbidity, and (3) multimodal strategies to improve survival among patients with bulky inguinal metastases. In this chapter, we will focus on the surgical evaluation and management of the ingu
Madrigal
发表于 2025-3-24 01:19:00
http://reply.papertrans.cn/63/6226/622576/622576_14.png
fabricate
发表于 2025-3-24 03:57:30
iation oncology, medical oncology and reconstructive surgery..Written by recognized experts in their field, .Management of Penile Cancer. is a unique and valuable resource in the field of penile cancer, both for those currently in training and for those already in clinical or research practice..978-1-4939-4753-9978-1-4939-0461-7
Muffle
发表于 2025-3-24 08:23:02
http://reply.papertrans.cn/63/6226/622576/622576_16.png
忘川河
发表于 2025-3-24 12:03:21
http://reply.papertrans.cn/63/6226/622576/622576_17.png
厌烦
发表于 2025-3-24 17:21:02
http://reply.papertrans.cn/63/6226/622576/622576_18.png
荧光
发表于 2025-3-24 20:58:21
Introduction to the Management of Penile Cancer,tial genetic and circulating tumor markers; and an overview of prognostic factors for penile cancer. Next, there is a critical review of current and newer imaging techniques for the detection, clinical staging, and surveillance of penile cancer with a critical assessment of their utility in each of these applications.
闲逛
发表于 2025-3-25 01:26:33
Prognostic Factors,ill allow the provider to carefully select patients for intervention on the lymph nodes while avoiding the potential side effect that such intervention may generate. Furthermore, a clear understanding of the factors which predict for survival will allow for optimal selection of patients for clinical trials.